Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Familial Cancer
Published in: Familial Cancer 4/2005

01-11-2005

Long Term Follow-up of HNPCC Gene Mutation Carriers: Compliance with Screening and Satisfaction with Counseling and Screening Procedures

Authors: Anja Wagner, Ingrid van Kessel, Mieke G. Kriege, Carli M. J. Tops, Juul Th. Wijnen, Hans F. A. Vasen, Conny A. van der Meer, Iris I. H. van Oostrom, Hanne Meijers-Heijboer

Published in: Familial Cancer | Issue 4/2005

Login to get access
Metadata
Title
Long Term Follow-up of HNPCC Gene Mutation Carriers: Compliance with Screening and Satisfaction with Counseling and Screening Procedures
Authors
Anja Wagner
Ingrid van Kessel
Mieke G. Kriege
Carli M. J. Tops
Juul Th. Wijnen
Hans F. A. Vasen
Conny A. van der Meer
Iris I. H. van Oostrom
Hanne Meijers-Heijboer
Publication date
01-11-2005
Publisher
Kluwer Academic Publishers
Published in
Familial Cancer / Issue 4/2005
Print ISSN: 1389-9600
Electronic ISSN: 1573-7292
DOI
https://doi.org/10.1007/s10689-005-0658-9

Other articles of this Issue 4/2005

Familial Cancer 4/2005 Go to the issue

OriginalPaper

Acknowledgements

OriginalPaper

Behavioral and Economic Impact of a Familial History of Cancers

Short communication

Linkage of a Pedigree Drawing Program and Database to a Program for Determining BRCA Mutation Carrier Probability

OriginalPaper

Survival of Patients with Ovarian Cancer due to a Mismatch Repair Defect

Short communication

Lack of Germ-line Mutations at the Specific BRCA1-IRIS Coding Sequence in 114 Spanish High-risk Breast/ovarian Families

OriginalPaper

Contents Volume 4
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits